We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$53.6B
AUM Growth
+$2.66B
(+5.2%)
Cap. Flow
+$86.8M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
821
New
56
Increased
227
Reduced
258
Closed
253
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$86.2M |
| 2 |
Alcon
ALC
|
+$81.8M |
| 3 |
NVIDIA
NVDA
|
+$76M |
| 4 |
Corning
GLW
|
+$50.4M |
| 5 |
UnitedHealth
UNH
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$67.4M |
| 2 |
Factset
FDS
|
+$62M |
| 3 |
Euronet Worldwide
EEFT
|
+$42.3M |
| 4 |
Bank of America Series L
BAC.PRL
|
+$39.5M |
| 5 |
OPLN
Openlane
OPLN
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Financials | 11.65% |
| 4 | Healthcare | 11.2% |
| 5 | Communication Services | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBM
201
DELISTED
Cambrex Corporation
CBM
| $18.2M | 0.03% |
389,650
-202,804
| -34% | -$8.51M |
|
202
National Vision
EYE
$1.8B
| $18.2M | 0.03% |
+591,884
| New | +$17M |
|
|
JBTM
203
JBT Marel
JBTM
$6.33B
| $18.2M | 0.03% |
150,022
-5,189
| -3% | -$558K |
|
204
Genpact
G
$6.13B
| $18.2M | 0.03% |
477,025
-3,991
| -0.8% | -$145K |
|
205
PTC
PTC
$16B
| $18M | 0.03% |
200,819
-12,105
| -6% | -$1.08M |
|
|
LSXMK
206
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $17.3M | 0.03% |
599,513
+68,737
| +13% | +$2.01M |
|
207
Trimble
TRMB
$13.6B
| $17.3M | 0.03% |
383,487
-23,168
| -6% | -$963K |
|
208
Paylocity
PCTY
$8.04B
| $17.2M | 0.03% |
183,333
-11,017
| -6% | -$1.05M |
|
209
Diamondback Energy
FANG
$53.1B
| $17.1M | 0.03% |
157,035
-12,000
| -7% | -$1.25M |
|
210
Malibu Boats
MBUU
$562M
| $17.1M | 0.03% |
439,690
+13,243
| +3% | +$526K |
|
211
NorthWestern Energy
NWE
$4.32B
| $16.8M | 0.03% |
233,501
-19,122
| -8% | -$1.36M |
|
|
PPLI
212
People Inc
PPLI
$3.2B
| $16.7M | 0.03% |
429,979
-151,725
| -26% | -$6.05M |
|
|
WLL
213
DELISTED
Whiting Petroleum Corporation
WLL
| $16.7M | 0.03% |
11,899
+189
| +2% | +$325K |
|
214
Wintrust Financial
WTFC
$10.7B
| $16.6M | 0.03% |
226,425
-5,462
| -2% | -$399K |
|
215
MarketAxess Holdings
MKTX
$5.72B
| $16.5M | 0.03% |
51,424
-17,992
| -26% | -$5.2M |
|
216
Fidelity National Financial
FNF
$14.1B
| $16.4M | 0.03% |
424,201
+156,951
| +59% | +$5.92M |
|
217
Employers Holdings
EIG
$908M
| $16.4M | 0.03% |
388,213
-65,066
| -14% | -$2.72M |
|
218
LCI Industries
LCII
$2.57B
| $16.3M | 0.03% |
181,569
-5,635
| -3% | -$498K |
|
219
Broadridge
BR
$18.8B
| $16.3M | 0.03% |
127,873
-14,673
| -10% | -$1.77M |
|
220
Baidu
BIDU
$37.1B
| $16.3M | 0.03% |
138,711
+45,480
| +49% | +$6.48M |
|
221
Adaptive Biotechnologies
ADPT
$3.75B
| $16.2M | 0.03% |
+336,042
| New | +$14.9M |
|
222
Insperity
NSP
$1.96B
| $16.2M | 0.03% |
132,740
-6,902
| -5% | -$832K |
|
223
Marriott Vacations Worldwide
VAC
$4.28B
| $16.2M | 0.03% |
167,858
-84,267
| -33% | -$8.31M |
|
|
ZGNX
224
DELISTED
Zogenix, Inc.
ZGNX
| $16.1M | 0.03% |
336,650
-98,532
| -23% | -$3.97M |
|
|
QVCGA
225
DELISTED
QVC Group Inc Series A
QVCGA
| $16.1M | 0.03% |
26,700
+2,023
| +8% | +$1.44M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2019 Portfolio in Review
As of Q2 2019, Loomis, Sayles & Company held 821 positions worth $53.6B, up 5.2% from $50.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Loomis, Sayles & Company's Q2 2019 filing shows 56 new, 227 increased, 258 reduced and 253 closed positions. Its largest new stake was Alcon: 1,393,674 shares worth $86.5M. The largest sale was Novartis, an estimated $67.4M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q2 2019 buy was Alcon: 1,393,674 shares worth $86.5M.
- Loomis, Sayles & Company added most to Bristol-Myers Squibb in Q2 2019, an estimated $86.2M increase.
- Loomis, Sayles & Company's biggest Q2 2019 reduction was Novartis, cutting an estimated $67.4M.
- Loomis, Sayles & Company fully exited RingCentral in Q2 2019, selling an estimated $30.4M.
- Loomis, Sayles & Company's ten largest holdings make up 37% of its $53.6B portfolio in Q2 2019.
- Loomis, Sayles & Company opened 56 new positions and closed 253 in Q2 2019.
- Loomis, Sayles & Company's portfolio value rose 5.2% quarter-over-quarter to $53.6B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.